Mankind Pharma slipped 3.51% to Rs 2,444.25 after the company's consolidated net profit declined 10.71% to Rs 420.77 crore in Q4 FY25 as against Rs 471.24 crore posted in Q4 FY24.

In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 22th of May, the Company's Chair of the ...

(Reuters) -U.S. prices for newly-launched pharmaceuticals more than doubled last year compared to 2021, as companies ...

UK biopharmaceutical companies saw a surge in venture financing for innovator drugs in 2024, with double the total deal value ...

Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is ...

Centum Electronics, Container Corporation of India, Gandhar Oil Refinery (India), GMR Airports, Goodluck India, Grasim ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

Large and midcap indices delivered similar 1-year returns, with Nifty Midcap 100 slightly outperforming Nifty 100. Smallcaps ...

The board recommended a final dividend of ₹3 per equity share of face value of ₹10 each (at the rate of 30%) for the ...

As many as eight important names like ITC, Sun Pharmaceutical Industries, Grasim Industries, GMR Airports, Container ...

ABU DHABI,19th May, 2025 (WAM) -- Basel Ziyadeh, CEO of Gulf Pharmaceutical Industries (Julphar), affirmed that the company ...

Discover how hot melt extrusion supports polypharmacy reduction and novel therapies for stroke and snakebite with expert insights.